Literature DB >> 19093877

Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers.

Pui-Chi Lo1, Juan Chen, Klara Stefflova, Michael S Warren, Roya Navab, Bizhan Bandarchi, Stefanie Mullins, Ming Tsao, Jonathan D Cheng, Gang Zheng.   

Abstract

Fibroblast activation protein (FAP) is a cell-surface serine protease highly expressed on cancer-associated fibroblasts of human epithelial carcinomas but not on normal fibroblasts, normal tissues, and cancer cells. We report herein a novel FAP-triggered photodynamic molecular beacon (FAP-PPB) comprising a fluorescent photosensitizer and a black hole quencher 3 linked by a peptide sequence (TSGPNQEQK) specific to FAP. FAP-PPB was effectively cleaved by both human FAP and murine FAP. By use of the HEK293 transfected cells (HEK-mFAP, FAP(+); HEK-vector, FAP(-)), systematic in vitro and in vivo experiments validated the FAP-specific activation of FAP-PPB in cancer cells and mouse xenografts, respectively. FAP-PPB was cleaved by FAP, allowing fluorescence restoration in FAP-expressing cells while leaving non-expressing FAP cells undetectable. Moreover, FAP-PPB showed FAP-specific photocytotoxicity toward HEK-mFAP cells whereas it was non-cytotoxic toward HEK-Vector cells. This study suggests that the FAP-PPB is a potentially useful tool for epithelial cancer detection and treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19093877      PMCID: PMC2773291          DOI: 10.1021/jm801052f

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  43 in total

1.  Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers.

Authors:  J Niedermeyer; M J Scanlan; P Garin-Chesa; C Daiber; H H Fiebig; L J Old; W J Rettig; A Schnapp
Journal:  Int J Cancer       Date:  1997-05-02       Impact factor: 7.396

2.  Abrogation of fibroblast activation protein enzymatic activity attenuates tumor growth.

Authors:  Jonathan D Cheng; Matthildi Valianou; Adrian A Canutescu; Eileen K Jaffe; Hyung-Ok Lee; Hao Wang; Jack H Lai; William W Bachovchin; Louis M Weiner
Journal:  Mol Cancer Ther       Date:  2005-03       Impact factor: 6.261

3.  Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion.

Authors:  Akira Orimo; Piyush B Gupta; Dennis C Sgroi; Fernando Arenzana-Seisdedos; Thierry Delaunay; Rizwan Naeem; Vincent J Carey; Andrea L Richardson; Robert A Weinberg
Journal:  Cell       Date:  2005-05-06       Impact factor: 41.582

Review 4.  Fibroblast activation protein-alpha and dipeptidyl peptidase IV (CD26): cell-surface proteases that activate cell signaling and are potential targets for cancer therapy.

Authors:  Thomas Kelly
Journal:  Drug Resist Updat       Date:  2005-04-07       Impact factor: 18.500

Review 5.  Cancer nanotechnology: opportunities and challenges.

Authors:  Mauro Ferrari
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

Review 6.  Tumor-stroma interactions: their role in the control of tumor cell invasion.

Authors:  P Zigrino; S Löffek; C Mauch
Journal:  Biochimie       Date:  2005 Mar-Apr       Impact factor: 4.079

7.  Tumor imaging by means of proteolytic activation of cell-penetrating peptides.

Authors:  Tao Jiang; Emilia S Olson; Quyen T Nguyen; Melinda Roy; Patricia A Jennings; Roger Y Tsien
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-15       Impact factor: 11.205

Review 8.  Tumour-stroma interaction: cancer-associated fibroblasts as novel targets in anti-cancer therapy?

Authors:  Patrick Micke; Arne Ostman
Journal:  Lung Cancer       Date:  2004-08       Impact factor: 5.705

9.  Mouse fibroblast-activation protein--conserved Fap gene organization and biochemical function as a serine protease.

Authors:  J Niedermeyer; B Enenkel; J E Park; M Lenter; W J Rettig; K Damm; A Schnapp
Journal:  Eur J Biochem       Date:  1998-06-15

Review 10.  Stromal fibroblasts in cancer initiation and progression.

Authors:  Neil A Bhowmick; Eric G Neilson; Harold L Moses
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

View more
  14 in total

1.  Vision 20/20: Molecular-guided surgical oncology based upon tumor metabolism or immunologic phenotype: Technological pathways for point of care imaging and intervention.

Authors:  Brian W Pogue; Keith D Paulsen; Kimberley S Samkoe; Jonathan T Elliott; Tayyaba Hasan; Theresa V Strong; Daniel R Draney; Joachim Feldwisch
Journal:  Med Phys       Date:  2016-06       Impact factor: 4.071

2.  Activatable near-infrared fluorescent probe for in vivo imaging of fibroblast activation protein-alpha.

Authors:  Jinbo Li; Kai Chen; Hongguang Liu; Kai Cheng; Meng Yang; Jiping Zhang; Jonathan D Cheng; Yan Zhang; Zhen Cheng
Journal:  Bioconjug Chem       Date:  2012-07-31       Impact factor: 4.774

3.  Design and synthesis of phospholipase C and A2-activatable near-infrared fluorescent smart probes.

Authors:  Anatoliy V Popov; Theresa M Mawn; Soungkyoo Kim; Gang Zheng; E James Delikatny
Journal:  Bioconjug Chem       Date:  2010-10-20       Impact factor: 4.774

4.  Stromal interactions as regulators of tumor growth and therapeutic response: A potential target for photodynamic therapy?

Authors:  Jonathan P Celli
Journal:  Isr J Chem       Date:  2012-07-24       Impact factor: 3.333

5.  Label-Free, Longitudinal Visualization of PDT Response In Vitro with Optical Coherence Tomography.

Authors:  Yookyung Jung; Alexander J Nichols; Oliver J Klein; Emmanuel Roussakis; Conor L Evans
Journal:  Isr J Chem       Date:  2012-09-13       Impact factor: 3.333

6.  Molecular photoacoustic imaging of follicular thyroid carcinoma.

Authors:  Jelena Levi; Sri-Rajashekar Kothapalli; Sarah Bohndiek; Joon-Kee Yoon; Anca Dragulescu-Andrasi; Carsten Nielsen; Aleksandra Tisma; Sunil Bodapati; Gayatri Gowrishankar; Xinrui Yan; Carmel Chan; Daniela Starcevic; Sanjiv Sam Gambhir
Journal:  Clin Cancer Res       Date:  2013-01-24       Impact factor: 12.531

7.  Platform to Discover Protease-Activated Antibiotics and Application to Siderophore-Antibiotic Conjugates.

Authors:  Jonathan H Boyce; Bobo Dang; Beatrice Ary; Quinn Edmondson; Charles S Craik; William F DeGrado; Ian B Seiple
Journal:  J Am Chem Soc       Date:  2020-12-10       Impact factor: 15.419

8.  Multimodal bacteriochlorophyll theranostic agent.

Authors:  Tracy W B Liu; Juan Chen; Laura Burgess; Weiguo Cao; Jiyun Shi; Brian C Wilson; Gang Zheng
Journal:  Theranostics       Date:  2011-08-23       Impact factor: 11.556

9.  Protease-activated drug development.

Authors:  Ki Young Choi; Magdalena Swierczewska; Seulki Lee; Xiaoyuan Chen
Journal:  Theranostics       Date:  2012-02-08       Impact factor: 11.556

Review 10.  Imaging aspects of the tumor stroma with therapeutic implications.

Authors:  Lian Narunsky; Roni Oren; Filip Bochner; Michal Neeman
Journal:  Pharmacol Ther       Date:  2013-10-14       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.